Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.
Neurofilament light chain level is a weak risk factor for the development of MS.
"Immunometabolism and autoimmunity".
TRAIL gene expression analysis in multiple sclerosis patients.
Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.
Differential diagnosis, discerning depression from cognition.
Is disability measured by FIM a predictor for successful self-intermittent catheterization in neurological patients?
Transfer of folate to the fetus.
Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I.
Charcot-Marie-Tooth neuropathy due to a novel EGR2 gene mutation with mild phenotype - Usefulness of human mapping chip linkage analysis in a Czech family.
The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis.
Neurotherapeutic Strategies for Multiple Sclerosis.
Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US.
Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.
Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.
Effect of fampridine on axonal excitability in multiple sclerosis.
Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.
Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis.
Corrigendum.
NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.
Interleukin-1β impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion.

Pages